Clinical Trial Update: Safety and Efficacy Trial With Zoledronic Acid for the Treatment of Paget's Disease of Bone, Including an Extended Observation Period [Phase 3]

View source ↗

Summary

A Phase 3 safety and efficacy trial of zoledronic acid for Paget's disease of bone completed, with results posted in 2012 after an extended observation period.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Paget Disease of Bone

Drugs mentioned

• Zoledronic acid (Zometa) (zoledronic acid)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Paget's Disease of Bone | Phase 3 | Status: COMPLETED | Results posted: 2012-05-02